Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3065-3080

  Nurhasni, Hasan ^a   Cao, Jiafu ^a   Choi, Moonjeong ^a   Kim, Il ^a   Lee, Bok Luel ^a   Jung, Yunjin ^a   Yoo, Jin Wook ^a  

^a Pusan National University   (South Korea)

Author keywords

Antimicrobial; Nitric oxide releasing nanoparticles; PEI; PLGA; Wound healing

Indexed keywords

NANOPARTICLE; NITRIC OXIDE; POLYETHYLENEIMINE; POLYGLACTIN; POLYGLACTIN POLYETHYLENIMINE NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; EPITHELIZATION; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IN VITRO STUDY; INFRARED SPECTROSCOPY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SURFACE CHARGE; TOXICITY TESTING; ULTRAVIOLET SPECTROPHOTOMETRY; WOUND HEALING; WOUND INFECTION; ZETA POTENTIAL; ANIMAL; BACTERIUM; CELL LINE; CHEMISTRY; DRUG EFFECTS; MOUSE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL LINE; LACTIC ACID; MICE; NANOPARTICLES; NITRIC OXIDE; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; WOUND HEALING;

EID: 84928150440     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S82199     Document Type: Article

References (41)

1. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430(6996):242-249.
2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-1743.
3. Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc. 2001;6(3): 170-174.
4. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99(11):7687-7692.
5. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373-1406.
6. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci: epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am. 1997;11(4):813-849.
7. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17(2):91-96.
8. Coates A, Hu Y. Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol. 2007;152(8):1147-1154.
9. Scatena R, Bottoni P, Pontoglio A, Giardina B. Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. Curr Med Chem. 2010;17(1):61-73.
10. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-789.
11. Burgner D, Rockett K, Kwiatkowski D. Nitric oxide and infectious diseases. Arch Dis Child. 1999;81(2):185-188.
12. Efron DT, Most D, Barbul A. Role of nitric oxide in wound healing. Curr Opin Clin Nutr Metab Care. 2000;3(3):197-204.
13. Gu H, Ho P, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano letters. 2003;3(9): 1261-1263.
14. Sambhy V, MacBride MM, Peterson BR, Sen A. Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials. J Am Chem Soc. 2006;128(30):9798-9808.
15. Whitesides GM. Nanoscience, nanotechnology, and chemistry. Small. 2005;1(2):172-179.
16. Lu Y, Slomberg DL, Sun B, Schoenfisch MH. Shape-and Nitric Oxide Flux-Dependent Bactericidal Activity of Nitric Oxide-Releasing Silica Nanorods. Small. 2013;9(12):2189-2198.
17. Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces. 2013;5(19):9322-9329.
18. Lu Y, Slomberg DL, Shah A, Schoenfisch MH. Nitric oxide-releasing amphiphilic poly(amidoamine)(PAMAM) dendrimers as antibacterial agents. Biomacromolecules. 2013;14(10):3589-3598.
19. Lu Y, Sun B, Li C, Schoenfisch MH. Structurally diverse nitric oxide-releasing poly(propylene imine) dendrimers. Chem Mater. 2011;23(18): 4227-4233.
20. Lu Y, Slomberg DL, Schoenfisch MH. Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. Biomaterials. 2014;35(5): 1716-1724.
21. Huang SL, Kee PH, Kim H, et al. Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. J Am Coll Cardiol. 2009;54(7):652-659.
22. Nablo BJ, Rothrock AR, Schoenfisch MH. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials. 2005;26(8):917-924.
23. Choi JS, Cao J, Naeem M, et al. Size-controlled biodegradable nanoparticles: Preparation and size-dependent cellular uptake and tumor cell growth inhibition. Colloids Surf B Biointerfaces. 2014;122:545-551.
24. Choi JS, Seo K, Yoo JW. Recent advances in PLGA particulate systems for drug delivery. Journal of Pharmaceutical Investigation. 2012;42(3): 155-163.
25. Zhou Z, Annich GM, Wu Y, Meyerhoff ME. Water-soluble poly (ethylenimine)-based nitric oxide donors: Preparation, characterization, and potential application in hemodialysis. Biomacromolecules. 2006; 7(9):2565-2574.
26. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41(11):5113-5120.
27. Pearson JP, Pesci EC, Iglewski BH. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol. 1997;179(18):5756-5767.
28. Frost MC, Reynolds MM, Meyerhoff ME. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials. 2005;26(14): 1685-1693.
29. Wan A, Sun Y, Li H. Characterization of folate-graft-chitosan as a scaffold for nitric oxide release. Int J Biol Macromol. 2008;43(5):415-421.
30. Griess P. Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt "Ueber einige Azoverbindungen". [Comments on the discussion of the HH Weselsky and Benedict "on some azo compounds"]. Ber Dtsch Chem Ges. 1879;12(1):426-428. German.
31. Yoo JW, Lee JS, Lee CH. Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A. 2010; 92(4):1233-1243.
32. Gethin G. The significance of surface pH in chronic wounds. Wounds UK. 2007;3(3):52.
33. Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J Am Chem Soc. 2007;129(15):4612-4619.
34. Rothrock AR, Donkers RL, Schoenfisch MH. Synthesis of nitric oxide-releasing gold nanoparticles. J Am Chem Soc. 2005;127(26): 9362-9363.
35. Stasko NA, Fischer TH, Schoenfisch MH. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules. 2008;9(3):834-841.
36. Khalil H, Chen T, Riffon R, Wang R, Wang Z. Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52(5):1635-1641.
37. Su S, Panmanee W, Wilson JJ, et al. Catalase (KatA) Plays a Role in Protection against a Anaerobic Nitric Oxide in Pseudomonas aeruginosa. PloS One. 2014;9(3):e91813.
38. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99(12): 2818.
39. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials. 2009; 30(14):2782-2789.
40. Sun B, Slomberg DL, Chudasama SL, Lu Y, Schoenfisch MH. Nitric oxide-releasing dendrimers as antibacterial agents. Biomacromolecules. 2012;13(10):3343-3354.
41. Wong T, McGrath J, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol. 2007;156(6):1149-1155.